Olema – Talk Bio

Actionable Insights Powered by AI

Olema Secures $250 Million Funding for Pivotal Breast Cancer Trial Featuring Novartis’ Kisqali

5 months ago talkbio0Tagged Kisqali, Malignant neoplasm of breast, Novartis, Olema

Olema, Breast Cancer, Novartis, Kisqali, Pivotal Trial, Funding